{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:29:50Z","timestamp":1789612190057,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470336"],"award-info":[{"award-number":["81470336"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["182300410347"],"award-info":[{"award-number":["182300410347"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.exphem.2021.08.010","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T20:10:34Z","timestamp":1630354234000},"page":"52-59.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["miRNA-223-3p modulates ibrutinib resistance through regulation of the CHUK\/Nf-\u03bab signaling pathway in mantle cell lymphoma"],"prefix":"10.1016","volume":"103","author":[{"given":"Jingjing","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengsheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suran","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keshu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2021.08.010_bib0001","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1306220","article-title":"Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma","volume":"369","author":"Wang","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2021.08.010_bib0002","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0140-6736(15)00667-4","article-title":"Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study","volume":"387","author":"Dreyling","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2021.08.010_bib0003","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1182\/blood-2015-10-673145","article-title":"Post-ibrutinib outcomes in patients with mantle cell lymphoma","volume":"127","author":"Martin","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2021.08.010_bib0004","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/annonc\/mdv111","article-title":"Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes","volume":"26","author":"Cheah","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.exphem.2021.08.010_bib0005","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/hon.2380","article-title":"Predictive factors and outcomes for ibrutinib therapy in relapsed\/refractory mantle cell lymphoma\u2014a \u201creal world\u201d study","volume":"35","author":"Epperla","year":"2017","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.exphem.2021.08.010_bib0006","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/cr.2010.177","article-title":"Non-canonical NF-\u03baB signaling pathway","volume":"21","author":"Sun","year":"2011","journal-title":"Cell Res"},{"key":"10.1016\/j.exphem.2021.08.010_bib0007","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nm.3435","article-title":"Pharmacological and genomic profiling identifies NF-\u03baB-targeted treatment strategies for mantle cell lymphoma","volume":"20","author":"Rahal","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2021.08.010_bib0008","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nrd4140","article-title":"MicroRNAs and other non-coding RNAs as targets for anticancer drug development","volume":"12","author":"Ling","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.exphem.2021.08.010_bib0009","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2217\/epi.12.39","article-title":"Cascorbi I. miRNAs as mediators of drug resistance","volume":"4","author":"Haenisch","year":"2012","journal-title":"Epigenomics"},{"key":"10.1016\/j.exphem.2021.08.010_bib0010","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.yexcr.2012.04.014","article-title":"MiR-222 modulate multidrug resistance in human colorectal carcinoma by down-regulating ADAM-17","volume":"318","author":"Xu","year":"2012","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.exphem.2021.08.010_bib0011","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.2147\/OTT.S283486","article-title":"MiRNA-223-3p affects mantle cell lymphoma development by regulating the CHUK\/NF-\u0198B2 signaling pathway","volume":"14","author":"Yuan","year":"2021","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.exphem.2021.08.010_bib0012","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3892\/ijmm.2016.2588","article-title":"miR-223 enhances the sensitivity of non-small cell lung cancer cells to erlotinib by targeting the insulin-like growth factor-1 receptor","volume":"38","author":"Zhao","year":"2016","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.exphem.2021.08.010_bib0013","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1177\/1535370213497321","article-title":"MiR-223 modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells","volume":"238","author":"Yang","year":"2013","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.exphem.2021.08.010_bib0014","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/ni.1918","article-title":"MicroRNAs modulate the noncanonical transcription factor NF-\u03baB pathway by regulating expression of the kinase IKK\u03b1 during macrophage differentiation","volume":"11","author":"Li","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.exphem.2021.08.010_bib0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2014.06.023","article-title":"Ibrutinib treatment of CLL: The cancer fights back","volume":"26","author":"Young","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2021.08.010_bib0016","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1056\/NEJMoa1400029","article-title":"Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib","volume":"370","author":"Woyach","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2021.08.010_bib0017","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2217\/fon.09.72","article-title":"NF-\u03baB as a prognostic marker and therapeutic target in chronic lymphocytic leukemia","volume":"5","author":"Pepper","year":"2009","journal-title":"Future Oncol"},{"key":"10.1016\/j.exphem.2021.08.010_bib0018","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/sj.onc.1206056","article-title":"NF-\u03baB transcription factor induces drug resistance through MDR1 expression in cancer cells","volume":"22","author":"Bentires-Alj","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2021.08.010_bib0019","doi-asserted-by":"crossref","first-page":"7342","DOI":"10.1038\/sj.onc.1204926","article-title":"Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer","volume":"20","author":"Catz","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2021.08.010_bib0020","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1023\/A:1010987220034","article-title":"Transcriptional regulation of the BCL-X gene by NF-\u03baB is an element of hypoxic responses in the rat brain","volume":"26","author":"Glasgow","year":"2001","journal-title":"Neurochem Res"},{"key":"10.1016\/j.exphem.2021.08.010_bib0021","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.3390\/cancers12092569","article-title":"The value of serum MicroRNA expression signature in predicting refractoriness to bortezomib-based therapy in multiple myeloma patients","volume":"12","author":"Robak","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.exphem.2021.08.010_bib0022","first-page":"4749","article-title":"MiRNA-27a-3p induces temozolomide resistance in glioma by inhibiting NF1 level","volume":"12","author":"Li","year":"2020","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.exphem.2021.08.010_bib0023","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.3390\/cancers12092552","article-title":"The role of non-coding RNAs as prognostic factor, predictor of drug response or resistance and pharmacological targets, in the cutaneous squamous cell carcinoma","volume":"12","author":"Garofoli","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.exphem.2021.08.010_bib0024","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1631\/jzus.B2000076","article-title":"MicroRNAs involved in drug resistance of breast cancer by regulating autophagy","volume":"21","author":"Wen","year":"2020","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.exphem.2021.08.010_bib0025","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20194509","article-title":"Overexpression of microRNA-205-5p exerts suppressive effects on stem cell drug resistance in gallbladder cancer by downregulating PRKCE","volume":"40","author":"Zhang","year":"2020","journal-title":"Biosci Rep"},{"key":"10.1016\/j.exphem.2021.08.010_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153176","article-title":"miR-192 enhances sensitivity of methotrexate drug to MG-63 osteosarcoma cancer cells","volume":"216","author":"Bazavar","year":"2020","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.exphem.2021.08.010_bib0027","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1089\/cbr.2020.3575","article-title":"Knockdown of circHIPK3 facilitates temozolomide sensitivity in glioma by regulating cellular behaviors through miR-524-5p\/KIF2A-mediated PI3K\/AKT pathway","author":"Yin","year":"2021","journal-title":"Cancer Biotherapy and Radiopharmaceuticals."},{"key":"10.1016\/j.exphem.2021.08.010_bib0028","first-page":"1096","article-title":"[MiR-199a-5p affects sensitivity of acute myeloid leukemia to adriamycin by targeting DRAM1] [Chinese]","volume":"28","author":"Li","year":"2020","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.exphem.2021.08.010_bib0029","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9512793","article-title":"miR-520h stimulates drug resistance to paclitaxel by targeting the OTUD3\u2013PTEN axis in breast cancer","volume":"2020","author":"Geng","year":"2020","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.exphem.2021.08.010_bib0030","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13046-020-01648-1","article-title":"Circular RNA circ-CPA4\/let-7 miRNA\/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC)","volume":"39","author":"Hong","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.exphem.2021.08.010_bib0031","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.lungcan.2020.06.020","article-title":"MiR-320a is associated with cisplatin resistance in lung adenocarcinoma and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray data","volume":"147","author":"Lu","year":"2020","journal-title":"Lung Cancer"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X21002903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X21002903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:36:43Z","timestamp":1759567003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X21002903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":31,"alternative-id":["S0301472X21002903"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2021.08.010","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miRNA-223-3p modulates ibrutinib resistance through regulation of the CHUK\/Nf-\u03bab signaling pathway in mantle cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2021.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}